A novel inhibitor of topoisomerases designated as topostatin was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. Topostatin inhibited the relaxation of supercoiled pBR322 DNA by calf thymus topoisomerase I, and also inhibited the relaxation of supercoiled pBR322 DNA and decatenation of kinetoplast DNA by human placenta topoisomerase II. Topostatin had neither ability to stabilize the cleavable complex nor ability to intercalate into DNA strands. The inhibitor exhibited growth inhibitory activity against the tumor cells (SNB-75 and SNB-78) of central nervous system, but did not exhibit any antimicrobial activity against Gram-positive and Gram-negative bacteria, yeasts and fungi.
Topoisomerases I and II are nuclear enzymes that catalyze the concerted breaking and rejoining of DNA strands, and the enzymes are involved in producing the necessary topological and conformational changes in DNA which are critical to many cellular processes such as replication, recombination and transcription10). Topoisomerase I catalyzes the passage of the DNA strands through a transient single-strand break, while topoisomerase II catalyzes the passage of DNA double strands through a transient double-strand break11,12 As an additional, new topoisomerase inhibitor, we found an inhibitor designated as topostatin (Fig. 1) in the culture filtrate of Thermomonospora alba strain No. 1520 isolated from a soil sample. Topostatin is a novel microbial inhibitor which can inhibit both topoisomerases I and II and it has neither ability to stabilize the cleavable complex nor ability to intercalate into DNA strands. This report describes the taxonomy of producing organism, fermentation, purification procedure and biological activities of topostatin. The structure elucidation will be described in the following paper. 
Biological Activities of Topostatin
The effects of topostatin on the catalytic activities of topoisomerases I and II were examined by the relaxation and decatenation assays. Camptothecin and doxorubicin were used as specific inhibitors against topoisomerases I and II, respectively. As shown in Fig. 5 (A) , in the presence of increasing topostatin, topoisomerase I relaxation activity was inhibited and its IC50 was 
